Thread: MY HiCy update (not a sales pitch)!
View Single Post
Old 07-09-2008, 05:06 PM
Lyon Lyon is offline
Junior Member
  
Join Date: Feb 2008
Posts: 7
15 yr Member
Lyon Lyon is offline
Junior Member
 
Join Date: Feb 2008
Posts: 7
15 yr Member
Default
Quote:
Originally Posted by barb02 View Post
Does anyone know if there is a age limitation for this treatment? That is, are they using it primarily on younger patients without other health conditions that are not attributable to ms?
In the most recent article I've seen the oldest patient was 47. The one before that the oldest patient was 62 and in Douglas Gladstone's Stony Brook study the oldest seems to have been 52.

Additionally, in the paper "Multiple sclerosis: long-term remission after
a high dose of cyclophosphamide" Acta Neurol Scand 2005: 111: 195–198 DOI: 10.1111/j.1600-0404.2005.00340.x the female Brazilian subject who was accidentally overdosed in 1994 was 48.

JH's opinion is the one that counts but it seems that if you're healthy enough to withstand treatment, age doesn't seem to reduce effectiveness of the treatment.

I don't have any firsthand info regarding JH rules addressing age limitation in the open label treatment.

Bob
Last edited by Lyon; 07-09-2008 at 05:22 PM.
Lyon is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
barb02 (07-09-2008), starfish (07-09-2008), tovaxin_lab_rat (07-10-2008)